Abstract. Although many of the molecular interactions in kidney development are now well understood, the molecules involved in the specification of the metanephric mesenchyme from surrounding intermediate mesoderm and, hence, the formation of the renal progenitor population are poorly characterized. In this study, cDNA microarrays were used to identify genes enriched in the murine embryonic day 10.5 (E10.5) uninduced metanephric mesenchyme, the renal progenitor population, in comparison with more rostral derivatives of the intermediate mesoderm. Microarray data were analyzed using R statistical software to determine accurately genes differentially expressed between these populations. Microarray outliers were biologically verified, and the spatial expression pattern of these genes at E10.5 and subsequent stages of early kidney development was determined by RNA in situ hybridization. This approach identified 21 genes preferentially expressed by the E10.5 metanephric mesenchyme, including Ewing sarcoma homolog, 14-3-3 , retinoic acid receptor-␣, stearoyl-CoA desaturase 2, CD24, and cadherin-11, that may be important in formation of renal progenitor cells. Cell surface proteins such as CD24 and cadherin-11 that were strongly and specifically expressed in the uninduced metanephric mesenchyme and mark the renal progenitor population may prove useful in the purification of renal progenitor cells by FACS. These findings may assist in the isolation and characterization of potential renal stem cells for use in cellular therapies for kidney disease.
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There is increasing evidence from a number of organ systems that cells with at least multipotentiality (1,2) and possibly pluripotentiality (3) exist in adult organs that previously were thought not to contain such populations. Although cell division is infrequent in the adult kidney, this organ possesses the capacity for regeneration as evidenced by the cellular proliferation observed during recovery from conditions such as acute tubular necrosis (4) . Although cell lineage relationships during renal repair and regeneration are poorly defined, it is possible that these processes recapitulate some aspects of embryonic renal development. The permanent kidney (metanephros) arises via reciprocal interactions between two tissues, the ureteric bud (UB) and the metanephric mesenchyme (MM) (5) . Each of these tissues is initially derived from the intermediate mesoderm (IM), although the UB develops as a caudal outgrowth from the nephric duct (ND), whereas the MM develops from the nephrogenic cord, the same block of tissue that gives rise to the pronephroi and the mesonephroi (5) . After invasion by the UB, cells of the MM are induced to differentiate into specific renal lineages. The central dogma of kidney development suggests that the UB forms the ureter and collecting duct system of the mature kidney, whereas the MM gives rise to the remaining portions of the nephrons, from Bowman's capsule to distal tubule (6) . Although many of the interactions between the UB and MM are now well characterized, the processes by which the MM initially differentiates from surrounding IM and becomes committed to a renal fate remain poorly understood.
The uninduced MM is composed of a few thousand morphologically similar mesenchymal cells. Tissue recombination experiments have shown the MM is the only embryonic cell population that can be induced to undergo nephrogenesis (5) . The uninduced MM has been proposed to be the renal progenitor population because it has the ability to differentiate into many more differentiated cell types than UB precursors (7) . Several reports have generated evidence that support this notion. Lineage-tracing studies have suggested that uninduced MM cells not only have the potential to develop into all of the epithelial regions of the nephron but also can be incorporated into UB-derived collecting duct epithelia (8) . Further evidence for the developmental potential of this tissue was recognized when embryonic porcine metanephroi that were transplanted into immunodeficient mice developed nonrenal derivatives such as cartilage and bone in addition to mature glomeruli and tubules (9) . Several other studies of cell lines isolated from embryonic kidneys have indicated that the MM displays multipotentiality (7, 10, 11) , although in vivo experiments have yet to complement these findings. What is not presently known is whether the multipotentiality of the uninduced MM results from a homogeneous progenitor cell population that is able to form all renal derivatives or if the MM already contains a mixture of progenitor cells that are committed to forming the different lineages found in the mature kidney ( Figure 1A ) (12) . In either case, we refer to the cells that compose the committed but uninduced MM (embryonic day 10.5 [E10.5]) as the renal progenitor population.
Microarrays have been used to generate temporal profiles of gene expression over the course of metanephric development (13, 14) and to analyze the expression profiles of discrete kidney subcompartments (15) and renal cell lines (16) . Although these data represent important steps in the creation of a catalogue of gene expression during kidney development and The uninduced metanephric mesenchyme (MM) is proposed to be the renal progenitor population because it has the ability to give rise to many more differentiated cell types than the ureteric bud (UB). (B through D) Isolation of tissue for microarray analysis. Dashed lines indicate planes of dissection. Embryonic day 10.5 (E10.5) embryos were cut transversely below the forelimbs (B), and the hind portion then was cut longitudinally down the neural tube (C) with the tail removed. This produced two tissue pieces, each with the nephric duct (ND) and MM visible (D). The region of uninduced MM was located directly dorsal to the emerging UB. The dashed lines indicate the regions of tissue that were collected for microarray analysis. To ensure that the entire MM was isolated, the region indicated by the more caudal box was collected, leading to possible contamination from UB tissue. A region of intermediate mesoderm-derived tissue indicated by the rostral box, comprising ND, nephrogenic cord, and aorta-gonad mesonephros region, was taken from the same embryo. the establishment of a baseline for the future examination of mutant mice, to date, no study has applied microarray technology to the renal progenitor population. A greater understanding of the processes that leads to commitment of progenitors to renal differentiation and the identification of specific cell surface markers of renal progenitors is essential in the search for renal stem cells. The two main goals of this study were (1) to identify the earliest markers of commitment to renal differentiation and (2) to determine the cell surface molecule phenotype of renal progenitor cells. By comparing the gene expression profile of uninduced MM to more rostral IM-derived tissue, we have defined some of the earliest genes expressed that distinguish the uninduced MM from surrounding nonmetanephrogenic tissue. These genes represent markers that signify commitment of the renal progenitors to a metanephric fate and, as such, may prove useful in the search for renal stem cells in the mature postnatal kidney or in the induction of nonrenal stem cells to adopt a renal fate.
Materials and Methods

Tissue Collection and RNA Isolation
Naturally mated outbred female CD1 mice were culled by cervical dislocation (Animal Ethics Committee approval number IMB/479/02/ NIH). MM and rostral IM tissue was dissected from E10.5 embryos and snap-frozen on dry ice. Embryos were defined as E10.5 by the presence of 8 to 10 tail somites. E10.5 embryos were dissected transversely below the forelimbs and longitudinally along the neural tube to expose the ND, UB, and MM ( Figure 1 ). Uninduced MM was identified spatially as the area immediately dorsal to the caudal terminus of the ND, from which the primitive UB had just begun to emerge. The emerging UB and uninduced MM are located medial to the caudal third of the hindlimb bud at E10.5, approximately halfway between the dorsal and ventral sides of the embryo and adjacent but medial to the mesonephric duct. IM tissue rostral to the MM, comprising the mesonephros and genital ridge, was dissected from the same embryos that were used for MM collection. Dissections were performed in cold PBS, and pooled tissue was stored at Ϫ80°C. Tissue was collected from 65 embryos, representing eight litters, and pooled for RNA isolation. Total RNA was prepared using Trizoll (Gibco BRL) extraction and cleaned with RNeasy mini kits (Qiagen) including on-column DNase digestion (Qiagen). RNA concentration and quality were determined by both spectrophotometry and on bioanalyzer RNA micro-fluidic chips (Agilent) and visualized by agarose gel electrophoresis.
Target Amplification and Microarrays
Total RNA was linearly amplified using the messageAMP aRNA kit (Ambion). Briefly, 1000 ng of total RNA was reverse transcribed into cDNA using a T7 promoter-dT primer and amplified through an in vitro transcription reaction (12 h) using T7 RNA polymerase to produce antisense RNA (aRNA). Amplification reactions yielded a minimum of 20 g of aRNA. The quality and integrity of the aRNA were assessed by spectrophotometry and agarose gel electrophoresis before labeling. Five micrograms of each aRNA sample was reverse transcribed using random hexamers (Promega) into cDNA incorporating either Cy5-or Cy3-labeled dUTP (Amersham) and hybridized to microarray chips for 16 h at 45°C. Microarray analysis was performed in triplicate, including duplicate hybridizations using aRNA from independent amplification reactions (technical replicate for amplification) and dye swap replicates using the same pool of aRNA (technical replicate for labeling).
Arrays were produced by the SRC Microarray Facility, University of Queensland (ARC Centre for Functional and Applied Genomics). Experiments were performed using chips arrayed with the National Institutes of Health-National Institute of Aging (NIA) 15K mouse cDNA clone set (http://lgsun.grc.nia.nih.gov/cDNA/15k.html) in addition to a selection of custom clones submitted from the Institute for Molecular Bioscience (University of Queensland, Brisbane) and contained 15,989 elements in total (http://microarray.imb.uq.edu.au/). Every element was spotted in duplicate on each chip. The NIA 15K mouse clone set contained 15,247 expressed sequence tags (EST) derived from pre-and peri-implantation embryo, E12.5 female gonad/ mesonephros, and newborn ovary cDNA libraries (17) , thus making it an ideal gene set for this experiment. A total of 14,428 of these EST sequences map to Unigene/TIGR/Ensembl and represent 11,834 distinct transcripts after removal of duplicates.
Array Analysis and Bioinformatics
Hybridized slides were scanned with a GMS 418 array scanner (Genetic MicroSystems), and images were analyzed with Imagene 5.5 (Biodiscovery). Microarray data were uploaded into BioArray Software Environment (BASE) 1.2.10 (18) and analyzed with R statistical software using the LIMMA package (http://bioinf.wehi.edu.au/ limma/) with scripts developed by Ola Spjuth of the Linnaeus Centre for Bioinformatics (http://www.lcb.uu.se/baseplugins.php). Mean foreground signals were taken for each spot and normalized within each array using print-tip lowess without background correction to give a mean value of zero for the log ratios of the two channels within each print block. The final normalized values were used for Bstatistics calculations. B-statistics analysis included an allowance for the correlation between adjacent duplicate spots printed on the same array. Differential expression was defined using a robust statistical method rather than simple fold change. All genes were ranked using the B-statistic method, whereby both fold change and variance of signals in replicates are used to determine the likelihood that genes are truly differentially expressed. Genes with a B score Ͼ0 have a Ͼ50% probability of being truly differentially expressed. This analysis was executed using the Bio-conductor package that has been implemented as a plug-in tool in BASE. Normalized data were also exported from BASE into Genespring 5.1 for visualization and generation of lists of differentially expressed genes. Full documentation of cDNA array fabrication, gene content, experimental procedures, and all results is available for download in accordance with MIAME guidelines at http://kidney.scgap.org/base/index.phtml.
Representative sequences for differentially expressed EST were extracted from the National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/). Using BLAST (19) , each NIA EST sequence was mapped to an identical full-length RIKEN representative transcript/protein sequence (RTPS 6.3) (20) . BLAST hits were scored on the basis of a combination of three features: e-value, identity, and coverage-calculated from the alignment. The RIKEN RTPS 6.3 set was annotated with a prediction of secretory status and membrane organization (21) , and proteins were classified as belonging to one of six classes on the basis of the presence or absence of endoplasmic reticulum signal peptides and helical transmembrane domains (Table 1) . Signal peptides were predicted by a best of three independent prediction methods, whereas transmembrane domains were annotated by five prediction methods, with a minimum of three positive predictions required for the region of a domain to be predicted. Potential conflicts between predictions of signal peptide and a transmembrane domain at the amino terminal of the sequence were resolved by the application of an N-terminal filtering program (22) .
Metanephric Culture and Tissue Preparation
For RNA in situ hybridization, embryos were collected from outbred CD1 mice as above at days 10.5 and 12.5 of gestation. E10.5 embryos were cut transversely below the forelimbs and longitudinally down the midline to expose the ND, UB, and MM as for initial tissue collection. At E12.5, complete urogenital (UG) tracts were collected. For explant culture, metanephroi were isolated from E12.5 embryos and grown as explants for 2 d at 5% CO 2 at 37°C on 3.0-m polycarbonate transwell filters (Costar) in MEM supplemented with 10% FCS and 20 mM glutamine. Tissue for whole-mount in situ hybridization was fixed overnight in 4% PFA/PBS at 4°C.
RNA In Situ Hybridization
Expression patterns were analyzed by RNA in situ hybridization using digoxigenin-labeled sense and antisense riboprobes. Probes were synthesized as described previously (23) using pSPORT1 constructs that contained the NIA EST of interest (SRC Microarray facility). Probes were not fragmented by hydrolysis and were purified using Sephadex columns (Roche) after digestion of the vector with DNaseI (Promega) for 15 min at 37°C. Whole-mount in situ hybridizations were performed as described previously (24) with minor modifications. All probes were hybridized at 65°C, and post-antibody washes were reduced to 30 min. Tissue was mounted in Mount-Quick aqueous (Daido Sangyo), and photographs were taken using an Olympus AX70 compound microscope with Kodak Elite Ektachrome 160T color reversal film.
Results
The microarray expression profile of murine E10.5 uninduced MM, the renal progenitor time point, was examined by comparison with adjacent rostral IM, comprising the portion of the nephrogenic cord that contained the mesonephros and presumptive genital ridge. In this way, markers identifying the MM from UB and surrounding IM at the point of MM commitment were determined. A major aim was to find cell surface markers ubiquitously expressed by this mass of progenitors that may be useful in identifying other cells throughout development of the metanephros and in the mature kidney with a cell surface profile similar to that of the renal progenitor population. Cells in the adult kidney that show a molecular phenotype similar to the renal progenitor time point may represent a residual multipotent progenitor population.
Gene Expression Profile Analysis
Until recently, it has been difficult to perform meaningful expression profile studies in embryologic systems because of the limited amount of nucleic acid available from small amounts of tissue. This problem was circumvented in this study by using mRNA linear amplification. aRNA produced by in vitro transcription has been shown to have a correlation coefficient Ͼ0.95 to total RNA and aRNA produced using different amounts of template total RNA (25, 26) . To minimize nonlinearity and ensure consistency, all samples were amplified under exactly the same conditions at the same time.
The array experiment was performed with amplification replicates and included a dye reversal experiment to account for any dye bias. The three arrays were normalized to each other to give a comparable range of log ratios ( Figure 2 ). Using R statistical software, genes were ranked in decreasing order of duplicate-correlated B scores, with the highest B scores representing differentially expressed genes showing the highest statistical confidence (a B score Ͼ0 represents a Ͼ50% probability that the gene is differentially expressed). The B score was calculated for each spot on the array using normalized signal and background intensities regardless of signal strength compared with other spots on the array. By doing this, we were confidently able to identify differentially expressed genes that had low absolute signal strength (but significant compared with background noise) that may represent low-abundance transcripts. The 40 genes with the highest B-score values are shown in Table  2 , and the entire list of ranked genes from this analysis is available at http://kidney.scgap.org/extra_data/Rankedgenes.txt.
Normalized data were imported into Genespring 5.1 for visualization and further analysis. The magnitude (M) difference of a gene between samples was determined during Bstatistic calculation, and the fold change for each gene was determined in Genespring. Elements on the microarrays for which the target signal intensity fell below 400 relative fluorescence units (RFU) were considered not reliable for foldchange calculations. Ratio data from duplicate spots on each array were determined and averaged across experimental replicates, and a mean ratio of 1.80-fold was used as the cutoff for differential expression. Outliers of genes differentially expressed between samples were defined using the combination of a B score Ͼ0 and a fold change Ͼ1.80-fold. Genes that showed increased differential expression in the MM are listed in Table 3 , whereas genes that were more highly expressed in IM are listed in Table 4 . The target intensity signals of these outliers ranged from 455 to 42452 RFU, suggesting that this approach was identifying both low-and high-expressing genes as outliers.
A total of 24 (21 nonredundant) elements with a B score Ͼ0
were found to have an average increase in differential expression Ͼ1.80-fold greater in the uninduced MM compared with the surrounding IM ( Table 3 ). The sequence of each differen- Table 3 for details). "no_match" indicates that the NIA sequence could not be mapped to a corresponding RIKEN full-length RTS transcript. No prediction could be made in this case.
b Average fold change in differential expression of triplicate hybridizations (Genespring).
c Membrane organization class prediction on the basis of RPS.
tially expressed EST was mapped to a full-length protein sequence from the RIKEN RTPS 6.3 set, and the membrane organization predictions were adopted for each gene of interest. Of particular interest were candidate genes from class C (type I membrane proteins), class D (type II membrane proteins), and class E (multispan membrane proteins) for their potential utility in antibody-based fluorescence-activated cell sorting (FACS) for the purification of renal progenitors. Six genes fell into this category.
Molecules that Identify the Renal Progenitor Time Point
The microarray comparison was done to identify molecules that spatially define the uninduced MM from surrounding tissue at E10.5. This experiment did not make any assumptions about what happened to the temporal expression and distribution of these molecules during subsequent important stages of early metanephric development. These questions were approached using in situ hybridization analysis. Initially, the expression patterns of these genes in E10.5 embryo whole mounts was analyzed to observe expression at the renal progenitor time point and verify the microarray data. RNA in situ analysis was also performed on E12.5 urogenital tracts to observe how specific expression of the gene was in the metanephroi compared with the organs developing around it. Analysis of metanephric explants was also used to identify what individual renal cell types expressed the genes of interest.
The temporospatial expression patterns of genes in Table 3 were determined and appear in Figure 3 . Whole-mount RNA in situ analysis at E10.5 and E12.5 indicates that few of these are restricted to the MM, and although differential expression in the MM was verified, this was over a background of broad or ubiquitous expression. Such genes included heat-shock protein 60 kD, p53, retinol dehydrogenase 10, bone morphogenetic protein 7, H19, and enolase 1. In later renal development, as assessed in metanephric explant culture, specific expression patterns were observed for most of these genes. Islet1 was shown to be highly expressed in the urogenital sinus, suggesting that the differential expression between MM and IM was due to contamination of tissue caudal to the MM. Gata3 and RIKEN cDNA 1600029D21 gene were expressed in the ND and emerging UB at E10.5, and expression was also observed in UB derivatives in metanephric explants.
Four of the differentially expressed genes were clearly verified as being expressed within the MM itself at a higher level than surrounding tissue. These were Ewing sarcoma homolog (Ewsh), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 14-3-3 , retinoic acid receptor-␣ (RAR-␣), and stearoyl-CoA desaturase 2 (Scd2). In explant cultures, 14-3-3 and Scd2 showed similar expression patterns, being broadly expressed by epithelial segments, RAR-␣ was expressed in the renal interstitium, particularly the interstitium at the core of the explant, and Ewsh was expressed in cells that were undergoing mesenchymal-epithelial transition around UB tips.
Cell Surface Markers of Renal Progenitor Cells
Six transmembrane proteins showed a significant increase in expression in the E10.5 MM compared with the surrounding IM (Table 3) . Scd2 is known to be an intracellular transmembrane protein localized to the endoplasmic reticulum and was therefore not considered in the category of potential cell surface marker of renal progenitors. The in situ expression patterns of these genes were examined across the same tissue types (Figure 4) as for the nontransmembrane molecules in Figure 3 .
Two transmembrane genes claudin-6 and spint-2 were identified as outliers because of strong and very specific expression in the ND and emerging UB, with the UB expression resulting in the differential between the two populations being compared. The in situ expression of these two genes was very specific to the ND and primordial UB in the E10.5 embryo and to ND/UB derivatives in the E12.5 UG tract (spint-2 also showed strong expression in the gonads at E12.5) and metanephric explants. Expression was also observed in the mesonephroi at E12.5.
Although present in other areas of the embryo, expression of CD24 was strikingly specific to the uninduced MM population in the nephrogenic cord of the E10.5 embryo. CD24 was specifically expressed in the kidneys of the E12.5 UG tract, although weak expression was also observed in the ND at this time point, made difficult to see as a result of the strong expression in the kidneys. In explants, CD24 was expressed in epithelial cells of both UB and MM lineages, although not in the lower limbs of the S-shaped bodies that give rise to the glomeruli. Cadherin-11 showed expression throughout the mesoderm of the embryo at E10.5 but particularly the renal progenitor population. Expression of cadherin-11 became more widespread at E12.5 and was strongly expressed throughout the renal interstitium of the explant, particularly the cells surrounding the UB tips. The NIA EST BG072301 was mapped to a full-length RIKEN RTPS that was bioinformatically predicted to encode for a protein that contains multiple transmembrane domains. No other information about this molecule is available in the literature. There was apparently ubiquitous expression of this molecule across the embryo at E10.5 and E12.5, although the levels of expression were elevated in the E10.5 MM. In explants, expression was observed in the interstitium but particularly the mesenchymal cells bordering epithelial structures.
Genes Enriched in the Mesoderm Surrounding the Metanephric Mesenchyme
Microarray analysis identified 45 elements, representing 42 nonredundant genes, with a B score Ͼ0 and expressed Ͼ1.80-fold greater in the IM than the E10.5 MM (Table 4) . Genes encoding secreted molecules expressed specifically in the tissue surrounding the MM may be important in directing MM toward a renal fate. Secreted molecules (class B) such as periostin, and tissue inhibitor of metalloproteinase 3, which were more strongly expressed in the IM, may be involved in signaling to the MM to direct early renal cell fate decisions. Membrane organization could not be established for 20 of the Figure 3 . RNA in situ hybridizations of genes enriched in uninduced MM at E10.5 in the mouse. The expression pattern of each gene was surveyed across E10.5 embryos (HL, hind limb bud; arrows represent budding site of primitive ureteric bud), E12.5 urogenital tracts (G, gonad; Mt, metanephros; Ms, mesonephros), and metanephric explants. (A) Islet1 was not expressed in renal derivatives at any time point but was strongly expressed in the urogenital sinus. Hspd1 expression was widespread at E10.5 and E12.5, but stronger expression was observed in the MM at E10.5 and in the interstitium of metanephric explants. Gata3 was strongly expressed in the ND and UB at E10.5 and in UB derivatives in metanephric explants. Ewsh was strongly and specifically expressed in the MM at E10.5, the metanephroi at E12.5 and mesenchymal cells undergoing mesenchymal-epithelial transition in explants. p53 was weak and ubiquitous in all tissues analyzed. Unknown EST (BG072306) was widespread at E10.5 and E12.5 but showed enrichment in the MM at E10.5 and was expressed in the interstitium of explants. 14-3-3 was strongly and specifically expressed in the MM at E10.5, in the metanephroi at E12.5 (weakly in gonads and ND), and in condensing mesenchyme in explants (weakly UB). Rdh 10 was strongly expressed in the MM at E10.5 but was not specific as widespread expression was observed at this time point and E12.5 and explants. (B) RAR␣ was observed in the MM at E10.5 and the primary interstitium of explants but was not specific at E12.5. BMP-7 was enriched in the MM at E10.5 and metanephroi at E12.5 and expressed strongly in condensing mesenchyme in explants (weakly in UB). H19 expression was specific to the MM at E10.5 but not to the metanephroi at E12.5, although expression was highly upregulated in mesenchymal cells surrounding UB tips in explants. Scd2 was strongly expressed in the MM at E10.5 but broadly expressed throughout the UG tract at E12.5 and in epithelial segments of metanephric explants. Eno1 was strongly expressed in the MM at E10.5 and weakly in the ND and UB, strong again in the metanephroi at E12.5, and weakly in the ND and strongly in condensing mesenchyme in explants. RIKEN cDNA 1600029D21 gene was expressed weakly in the ND and MM at E10.5 but was highly upregulated in the emerging UB, was strongly expressed in the metanephroi at E12.5 (weakly in ND and mesonephroi), but strongly expressed in UB derivatives in explants (weakly in mesenchymal caps). Tcp1 was not specific at E10.5 and expressed in gonads and metanephroi at E12.5 with expression maintained in condensing mesenchyme in metanephric explants. RIKEN cDNA 1110034A24 gene was strongly but not specifically expressed in the MM at E10.5 and was also broadly expressed in E12.5 UG tracts and metanephric explants.
42 genes because the NIA sequence did not confidently map to a corresponding full-length protein-coding RIKEN transcript.
Discussion
The goal of this project was to find genes that identify renal progenitor cells in the uninduced MM at E10.5. Microarray analysis identified a subset of genes that were upregulated in the uninduced MM in comparison with adjacent rostral IM, whose expression was not broadly expressed at E10.5 and whose expression persisted during development but became restricted or reduced in expression over time. These markers include Ewsh, 14-3-3 , Scd2, RAR-␣, CD24, and cadherin-11. The intracellular markers may be crucial in specification of the MM and provide useful tools for identification of nonrenal stem cells being induced to adopt a kidney fate. The cell surface markers CD24 and cadherin-11 may prove useful in purification of potential renal progenitor cell populations by FACS.
CD24 was strongly and specifically expressed in all uninduced MM cells at E10.5, and cadherin-11 was also strongly expressed by this population. Although these molecules both seem to mark the renal progenitor time point, their expression patterns diverged greatly as kidney development progressed. In metanephric explants, CD24 expression was observed in all epithelial structures of the developing kidney except for the lower limbs of the S-shaped bodies, whereas cadherin-11 was expressed by mesenchymal cells of the renal interstitium, most strongly by those surrounding the UB tips, but not in epithelial cells. The fact that CD24 marks cell types of both MM and UB derivatives suggests that it identifies renal progenitors that are committed to differentiating into epithelial segments of the nephron, whereas cadherin-11 may identify progenitor cells Figure 4 . Whole-mount RNA in situ hybridizations of cell surface proteins representing renal progenitor cell markers. The expression pattern of each gene was surveyed across E10.5 embryos (arrows represent budding site of primitive UB), E12.5 urogenital tracts, and metanephric explants. Claudin-6 was highly specific to the ND and UB at E10.5, mesonephroi, ND and UB derivatives at E12.5, and UB derivatives in metanephric explants. Spint-2 was highly specific to the ND and UB at E10.5, the sex cords of the gonads, mesonephroi, ND and UB derivatives at E12.5, and UB derivatives in explants. CD24 was strikingly specific to the MM at E10.5 (in the nephrogenic cord) and the metanephroi at E12.5 with expression observed in epithelial segments of both MM and UB origin in explants. Cadherin-11 was strongly but not specifically expressed in the MM at E10.5 and in the metanephroi at E12.5 with expression observed in the interstitium of metanephric explants. Hypothetical protein (BG072301) was ubiquitous at E10.5 and E12.5, although enriched in the MM with expression observed in the interstitium of explants.
that are destined to form the primary renal interstitium. There is some indirect evidence to suggest that these molecules may mark a renal progenitor cell population. CD24 is strongly expressed in Wilms' tumors (27) and renal cell carcinomas (28) , and cadherin-11 expression has also been detected in renal cell carcinoma cell lines (29) and Wilms' tumors and is located on the long arm of chromosome 16, a region known to demonstrate allele loss in such tumors (30) . Expression of CD24 and cadherin-11 by renal tumor cells may indicate that these cells are reverting to a more primitive or embryonic state, a condition analogous to the uninduced MM at E10.5.
Ideally, markers of renal progenitors would be restricted to MM expression. Although the expression of CD24 and cadherin-11 during embryogenesis as a whole was not examined in this study, their expression is not restricted to the MM at E10.5 and has been described in other locations during development (31, 32) . This is not surprising, and in all other progenitor or stem cell populations, the markers used for enrichment are not restricted to those populations. Rather, it is a combination of expression and lack of expression that is used for isolation. Neither CD24 nor cadherin-11 is recognized as a positive marker of embryonic, neural, or hematopoietic stem cells. Indeed, murine neural stem cells are regarded as CD24 lo (3). However, CD24 has been identified as a marker of spermatogonial stem cells (33) , and links have been made between the expression of cadherin-11 and osteogenic progenitors (34) . The latter is interesting given the differentiation of bone and cartilage in Wilms' tumors. These molecules may represent cell surface markers of renal progenitor cells conserved between mouse and human, but their expression is not restricted to the uninduced MM. Therefore, as for other stem cell systems, it will be necessary to use these markers in combination with others to enrich for renal progenitors.
These experiments made no a priori assumptions about what happened to the expression and localization of these MM markers as metanephric development progressed, simply asking what defines the E10.5 MM renal progenitor time point as an entity from the tissue that surrounds it. Although the dogma has suggested that kidney development ceases at birth, the growing evidence of resident stem cell populations in a variety of adult organs suggests that such a population may also exist in the kidney. The location of such a population is unknown, as is the phenotype of such cells. Specific markers of renal progenitor cells that maintained expression in a rare adult stem cell population should decrease in abundance and become localized to specific cell types as the kidney differentiates and the progenitor pool becomes depleted. CD24 is known to remain expressed in the distal tubules (35) of the adult kidney, but this does not rule out the possibility that it is also expressed in a minor stem cell population of the adult kidney. Further analysis of the later expression patterns of these renal progenitor time-point genes may help to determine such a subcompartment. FACS analysis using combinations of the cell surface markers identified in this experiment could reveal whether minor populations of progenitor-like cells exist in the adult kidney. FACS analysis may also be applied to determine whether the renal progenitor time point represents a homogeneous population of progenitors or a collection of cell types with distinct renal lineage potential.
Several genes that are known to be involved in early metanephric development were identified as outliers in this microarray experiment. For example, Gata3 expression is crucial in early metanephric development as the MM of Gata3 null embryo fails to differentiate and renal hypoplasia occurs (36) and RAR-␣ double-null mutants have reduced UB growth (37) . Gene knockout models have suggested crucial roles for molecules such as WT-1 (38), Lim1 (39), Eya1 (40) , and Pax2 (41) in early metanephric development. Expression of these genes is thought to be some of the earliest signs of commitment of the metanephric mesenchyme to a renal fate. Many of these genes were not represented in the NIA clone set, and some genes that were present did not produce a signal strength that would allow a reliable determination of differential expression to be made compared with background noise, resulting in a B score Ͻ0. However, two genes involved in early metanephric development, the transcription factor WT-1 and the secreted morphogen wnt-4, showed higher expression in the IM compared with the MM in microarrays (fold change just below 1.80-fold threshold), findings verified by in situ hybridization (results not shown). This highlights that a comparison between IM and MM at E10.5 essentially represents a spatial comparison between mesonephros/presumptive genital ridge and MM. Hence, some genes that play important roles in metanephric development will initially be expressed to a higher degree in the mesonephros/genital ridge than the MM. This also shows how microarray experiments can be used only as a guide, and although they are efficient ways to survey thousands of genes, they must be used in combination with other techniques to uncover the roles of various genes in developmental processes.
In summary, for the first time, we have catalogued the expression profile of the MM at the point of commitment to a metanephric lineage. This analysis has identified Ewsh, RAR-␣, 14-3-3 , Scd2, CD24, and cadherin-11 as molecules that are highly expressed by renal progenitors. In addition, CD24 and cadherin-11 are cell surface markers at this time point. By distinguishing some of the earliest genes expressed by the uninduced MM, this study has not only identified novel molecules involved in metanephric development but also provided tools for the reverse transcription-PCR-based identification of embryonic stem (ES) cells that adopt a renal fate. The existence of a renal stem cell has not been established, and although recent discoveries in stem cell biology suggest that they might exist, no markers for renal stem or progenitor cells have been discovered, prohibiting the identification and isolation of such cells. By defining a combination of cell surface proteins that specifically mark the renal progenitor time point, this approach will facilitate purification of cells with this phenotype from mixed populations, such as kidneys at various stages of development or differentiating ES cell cultures, using antibody-based FACS.
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